Limpinsel Leonard, Dobler Gerhard, Borde Johannes P, Riehm Julia M, Girl Philipp
Bavarian Health and Food Safety Authority, Oberschleissheim 85764, Germany.
Bundeswehr Institute of Microbiology, Munich 80937, Germany; Dept. of Infectious Diseases and Tropical Medicine, LMU Center of Medicine, Munich 80336, Germany; Dept. of Parasitology, University of Hohenheim, Stuttgart 70599, Germany.
Vet Microbiol. 2025 Oct;309:110679. doi: 10.1016/j.vetmic.2025.110679. Epub 2025 Aug 11.
Brucellosis is a globally significant zoonotic disease, caused by Brucella spp., with wildlife reservoirs such as wild boars posing a potential threat to brucellosis-free livestock populations and public health. Despite eradication of brucellosis in domestic animals in Germany, the disease persists in wildlife. Reliable and specific diagnostic tools are essential for effective surveillance.
In this study, 149 serum samples from wild boars hunted during the 2023/2024 season in Bavaria (Germany) were analyzed using four serological tests: 1.the rose bengal test (RBT), 2. a conventional sLPS-based ELISA (BMS),3. a novel biwell ELISA (BSI) using both sLPS and rLPS antigens and 4. the complement fixation test (CFT) as gold standard. Sensitivity, specificity, and accuracy of all assays were calculated in comparison to the CFT.
Of the 149 samples analyzed, 9 tested positive by CFT, resulting in a seroprevalence of 6.0 % [3.1 %, 11.2 %]in the sampled wild boar population. The BMS-ELISA demonstrated the highest sensitivity (100 %) but moderate specificity (85.0 %), whereas the BSI ELISA showed improved specificity (94.3 %) and accuracy (92.6 %) through combined detection of antibodies against sLPS and rLPS, albeit with lower sensitivity (66.7 %). The RBT performed least favorably with a sensitivity of 55.6 % and specificity of 92.7 %.
The findings confirm that brucellosis remains endemic among wild boars in Bavaria. While the BSI ELISA shows promise due to its high specificity, its lower sensitivity limits its utility as a stand-alone diagnostic. Cross-reactions in sLPS-based assays highlight the importance of combining antigens for improved test reliability. The varying seroprevalence compared to previous studies underscores the dynamic nature of infection in wildlife populations.
A dual-step diagnostic approach - utilizing a sensitive ELISA for screening followed by CFT for confirmation - remains the most effective strategy for wildlife surveillance. The BSI ELISA may serve as a viable alternative in clinical or resource-limited settings. Continued monitoring is crucial to mitigate the zoonotic risk posed by wildlife reservoirs.
布鲁氏菌病是一种具有全球重要性的人畜共患病,由布鲁氏菌属引起,野猪等野生动物宿主对无布鲁氏菌病的牲畜群体和公共卫生构成潜在威胁。尽管德国已在家畜中根除了布鲁氏菌病,但该疾病仍在野生动物中存在。可靠且特异的诊断工具对于有效监测至关重要。
在本研究中,使用四种血清学检测方法对2023/2024狩猎季期间在德国巴伐利亚州猎获的149份野猪血清样本进行了分析:1. 虎红平板凝集试验(RBT);2. 基于常规光滑型脂多糖的酶联免疫吸附测定(BMS);3. 一种使用光滑型脂多糖(sLPS)和重组脂多糖(rLPS)抗原的新型双孔酶联免疫吸附测定(BSI);4. 补体结合试验(CFT)作为金标准。与CFT相比,计算了所有检测方法的敏感性、特异性和准确性。
在分析的149份样本中,有9份通过CFT检测呈阳性,在所采样的野猪群体中血清阳性率为6.0% [3.1%,11.2%]。BMS-酶联免疫吸附测定显示出最高的敏感性(100%),但特异性中等(85.0%),而BSI酶联免疫吸附测定通过联合检测抗sLPS和rLPS的抗体显示出更高的特异性(94.3%)和准确性(92.6%),尽管敏感性较低(66.7%)。RBT表现最差,敏感性为55.6%,特异性为92.7%。
研究结果证实布鲁氏菌病在巴伐利亚州的野猪中仍然流行。虽然BSI酶联免疫吸附测定因其高特异性显示出前景,但其较低的敏感性限制了其作为独立诊断方法的实用性。基于sLPS的检测中的交叉反应突出了组合抗原以提高检测可靠性的重要性。与先前研究相比,不同的血清阳性率强调了野生动物群体中感染的动态性质。
两步诊断方法——先使用敏感的酶联免疫吸附测定进行筛查,然后使用CFT进行确认——仍然是野生动物监测最有效的策略。BSI酶联免疫吸附测定在临床或资源有限的环境中可能是一种可行的替代方法。持续监测对于降低野生动物宿主带来的人畜共患病风险至关重要。